Clever Leaves Holdings Inc
OTC:CLVR
Net Margin
Clever Leaves Holdings Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CO |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
691.1 USD |
-103%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
729.1B USD |
23%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
362.8B USD |
24%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
207.2B CHF |
14%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
186.3B CHF |
24%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
161.6B GBP |
14%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
201.1B USD |
27%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
136.6B USD |
13%
|
Clever Leaves Holdings Inc
Glance View
Clever Leaves Holdings Inc. is a leading player in the global cannabis industry, with a mission to provide high-quality, sustainable, and compliant cannabinoid products. Founded in 2018 and headquartered in New York, this vertically integrated company has established a robust operational presence in key markets, including Colombia, the United States, and Europe. Clever Leaves differentiates itself with a focus on international cultivation and distribution, leveraging Colombia's ideal climate for cannabis production, resulting in cost-effective and high-quality products. This strategic positioning allows the company to cater to a diverse customer base, from pharmaceutical companies to consumer brands, as it navigates the emerging global cannabinoid landscape. As an investor, you’ll find that Clever Leaves embodies the principles of responsible growth and innovation through its unwavering commitment to compliance and quality. With multiple certifications enabling it to trade in international markets, the company is well-prepared to capitalize on the evolving regulations surrounding cannabis. Their expansive research and development initiatives, along with solid supply chain management, aim to unlock new product opportunities, positioning Clever Leaves for potential long-term success in the burgeoning cannabinoid sector. As the global market continues to mature, Clever Leaves is poised to take advantage of expanding consumer demand for cannabis-derived products, making it an intriguing investment opportunity for those looking to enter this dynamic and rapidly growing industry.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Clever Leaves Holdings Inc's most recent financial statements, the company has Net Margin of -102.8%.
You don't have any saved screeners yet